Teligent is a specialty generic pharmaceutical company which develops, formulates, manufactures, and markets generic topical, branded generic, and generic injectable pharmaceutical products. The Company sells generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms. It also develops, manufactures, fills, and packages topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as for over-the-counter and cosmetic markets. The Company's products are used in various applications that range from cosmetics and cosmeceuticals to the prescription treatment of conditions, such as dermatitis, psoriasis, and eczema. In addition, it offers contract formulation and contract manufacturing services.

Company Growth (employees)
Buena, US
Size (employees)
153 (est)+43%
Teligent was founded in 1977 and is headquartered in Buena, US

Teligent Office Locations

Teligent has offices in Buena, Toronto, Iselin and Tallinn
Buena, US (HQ)
105 Lincoln Avenue
Iselin, US
33 South Wood Ave, Suite 730
Toronto, CA
10 King Street East Suite 1500
Tallinn, EE
21/5 Akadeemia tee
Show all (4)

Teligent Financials and Metrics

Teligent Financials

Teligent's revenue was reported to be $66.9 m in FY, 2016

Revenue (Q1, 2017)

19.9 m

Gross profit (Q1, 2017)

10.9 m

Gross profit margin (Q1, 2017), %


Net income (Q1, 2017)

831 k

EBIT (Q1, 2017)

3 m

Market capitalization (31-Oct-2017)

303.3 m

Closing share price (31-Oct-2017)


Cash (31-Mar-2017)

59.5 m
Teligent's current market capitalization is $303.3 m.
USDFY, 2016


66.9 m

Cost of goods sold

32.2 m

Gross profit

34.7 m

Gross profit Margin, %

USDQ1, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017


6.9 m6.7 m10.7 m8.9 m11.6 m15.7 m17.1 m16.2 m19.9 m

Cost of goods sold

4 m4 m5 m5.2 m5.5 m7.7 m7.6 m8.1 m9 m

Gross profit

2.9 m2.6 m5.6 m3.7 m6.1 m8 m9.6 m8 m10.9 m

Gross profit Margin, %

USDFY, 2015FY, 2016


87.2 m66 m

Accounts Receivable

14 m21.7 m


9 m12.7 m

Current Assets

116.8 m103.3 m
USDQ1, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017


2.4 m23.2 m157 m150.2 m145.7 m87 m81.2 m74.6 m59.5 m

Accounts Receivable

4.1 m6.4 m16.3 m17.3 m10.9 m13.2 m15.5 m17.2 m25.2 m


2.7 m3.2 m3.7 m4.1 m5 m10.1 m11 m12.5 m14.3 m

Current Assets

9.9 m33.8 m178.4 m173.1 m163 m117.7 m110.6 m106.9 m101.9 m
USDFY, 2015FY, 2016

Net Income

6.7 m(12 m)

Accounts Receivable

1.3 m(7.7 m)


(3.6 m)(5 m)

Accounts Payable

(2.8 m)4.7 m
USDQ1, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

167 k(202 k)6.6 m9.4 m(2.9 m)(950 k)(2.9 m)(2.7 m)831 k

Accounts Receivable

17.3 m10.9 m13.2 m15.5 m17.2 m25.2 m


4.1 m5 m10.1 m11 m12.5 m14.3 m

Accounts Payable

2.6 m3 m4.4 m4 m3.8 m8.1 m
USDY, 2017


185.9 k

Financial Leverage

3.3 x
Show all financial metrics

Teligent Market Value History

Teligent's Web-traffic and Trends

Teligent Company Life and Culture

You may also be interested in